U.S. FDA Health Press Releases — RSS Feed & Live Monitoring
PPN World indexes U.S. FDA press releases and archives each one it distributes. This wire has been quiet since September 4, 2026 — its 63 indexed releases remain searchable, and an alert will tell you the moment it publishes again.
About this feed
U.S. FDA is one of the 1,200+ press-release feeds PPN World monitors around the clock — an English-language wire focused on Health, filed under United States in our country index. Every release is deduplicated, geotagged, and enriched with an AI summary, and you can attach saved-search alerts to any keyword it publishes. The most recent release in our index was published on September 4, 2026; the wire has been quiet since.
Track U.S. FDA in real time in PPN World
Every U.S. FDA release lands in the cockpit seconds after it publishes — deduplicated, classified, with saved-search alerts and AI summaries, alongside 1,200+ other wires. 7-day free trial, no card required.
Start the free trial →U.S. FDA press releases — archive
- FDA Takes Steps to Maintain Newborn Access to Life-Saving Starter Nutrition Products9 d ago
The U.S. Food and Drug Administration today announced it is taking action, consistent with the Trump administration’s commitment to protecting vulnerable patients and maintaining access to critical me…
- FDA Grants Accelerated Approval to a New Breast Cancer Treatment9 d ago
The U.S. Food and Drug Administration today expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing medical innovation and getting new t…
- FDA Approves First Drug to Treat Alexander Disease10 d ago
The U.S. Food and Drug Administration has approved Zanvastro (zilganersen) injection for the treatment of Alexander disease in pediatric and adult patients.
- FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World Screwworm in Dogs and Cats10 d ago
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Capstar (nitenpyram) tablets and revised the EUA for Nitenpyram Tablets, the generic version of Capstar
- FDA Seeks Public Input to Advance Development of Botanical Drug Products10 d ago
The U.S. Food and Drug Administration today announced a request for information (RFI) to gather public input on opportunities to advance the development of botanical drug products.
- FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder16 d ago
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cell…
- FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults17 d ago
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.
- FDA Issues Emergency Use Authorization for Generic Drug to Prevent New World Screwworm in Cattle17 d ago
FDA issues Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis) in cattle when administered within 24 hours of b…
- FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer18 d ago
The U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced…
- FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar19 d ago
The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
- FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia25 d ago
The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for adults and children 8 years of age and older…
- FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device25 d ago
The U.S. Food and Drug Administration today authorized the Aletta, the first standalone robotic device that can draw blood from a patient’s arm without hands-on operator intervention.
The newest releases on this wire stream live for PPN World members.